Literature DB >> 11523698

Distribution and mRNA expression of insulin-like growth factor system in pulmonary lymphangioleiomyomatosis.

J C Valencia1, K Matsui, C Bondy, J Zhou, A Rasmussen, K Cullen, Z X Yu, J Moss, V J Ferrans.   

Abstract

BACKGROUND: Insulin-like growth factors (IGF-1 and IGF-2), the IGF-1 receptor (IGF-1R), and IGF-binding proteins (IGFBPs) are involved in normal pulmonary development and in the pathogenesis of smooth muscle cell tumors.
METHODS: To evaluate the role of the IGF system in lymphangioleiomyomatosis (LAM), we used immunohistochemical and in situ hybridization techniques to characterize the expression of IGF-1, IGF-2, IGF-1R, and IGFBP-2, -4, -5, and -6 in lung tissue from 18 LAM patients.
RESULTS: IGF-1, ICGF-2, IGF-1R, IGFBP-1, IGFBP-2, IGFBP-4, IGFBP-5, and IGFBP-6 were expressed by LAM cells. Reactivity and mRNA expression for IGF-2 were observed in LAM cells and resembled that found in normal smooth muscle cells during pulmonary development as well as in smooth muscle cell tumors. IGFBP-2, IGFBP-4, and IGFBP-6 were associated with spindle-shaped LAM cells, whereas IGFBP-5 was associated mainly with epithelioid LAM cells.
CONCLUSIONS: These findings suggest that the IGFBPs modulate the effects of the IGFs on LAM cells. Thus, the patterns of localization and expression of components of the IGF system in LAM strongly suggest that these agents are involved in the proliferation of LAM cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523698     DOI: 10.2310/6650.2001.33787

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  17 in total

1.  Sorting of Pmel17 to melanosomes through the plasma membrane by AP1 and AP2: evidence for the polarized nature of melanocytes.

Authors:  Julio C Valencia; Hidenori Watabe; An Chi; Francois Rouzaud; Kevin G Chen; Wilfred D Vieira; Kaoruko Takahashi; Yuji Yamaguchi; Werner Berens; Kunio Nagashima; Jeffrey Shabanowitz; Donald F Hunt; Ettore Appella; Vincent J Hearing
Journal:  J Cell Sci       Date:  2006-02-21       Impact factor: 5.285

Review 2.  The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.

Authors:  Wendy K Steagall; Gustavo Pacheco-Rodriguez; Thomas N Darling; Olga Torre; Sergio Harari; Joel Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 6.914

3.  Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas.

Authors:  Kevin G Chen; Julio C Valencia; Barry Lai; Guofeng Zhang; Jill K Paterson; François Rouzaud; Werner Berens; Stephen M Wincovitch; Susan H Garfield; Richard D Leapman; Vincent J Hearing; Michael M Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-15       Impact factor: 11.205

4.  Involvement of lymphatics in lymphangioleiomyomatosis.

Authors:  Connie G Glasgow; Angelo Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Katsuya Tsukada; Xiong Cai; Souheil El-Chemaly; Joel Moss
Journal:  Lymphat Res Biol       Date:  2009-12       Impact factor: 2.589

Review 5.  Lymphangioleiomyomatosis and TSC2-/- cells.

Authors:  Thomas N Darling; Gustavo Pacheco-Rodriguez; Alfredo Gorio; Elena Lesma; Cheryl Walker; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

6.  The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.

Authors:  Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

7.  Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.

Authors:  Wendy K Steagall; Gustavo Pacheco-Rodriguez; Connie G Glasgow; Yoshihiko Ikeda; Jing-Ping Lin; Gang Zheng; Joel Moss
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

8.  Insights from gene arrays on the development and growth regulation of uterine leiomyomata.

Authors:  John C M Tsibris; James Segars; Domenico Coppola; Shrikant Mane; George D Wilbanks; William F O'Brien; William N Spellacy
Journal:  Fertil Steril       Date:  2002-07       Impact factor: 7.329

Review 9.  Lymphatic involvement in lymphangioleiomyomatosis.

Authors:  Connie G Glasgow; Angelo M Taveira-Dasilva; Thomas N Darling; Joel Moss
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

10.  Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.

Authors:  Julio C Valencia; Gustavo Pacheco-Rodriguez; Adriana K Carmona; Janina Xavier; Patrick Bruneval; William K Riemenschneider; Yoshihiko Ikeda; Zu-Xi Yu; Victor J Ferrans; Joel Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-10       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.